Trilipix Modified Release Capsules 45mg
Product details
Registration number: SIN14375P
Classification: Prescription Only
Active ingredients: Choline Fenofibrate 59.6mg eqv Fenofibric Acid
Strength: 45mg
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Route: ORAL
Registrant: ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
ATC code: C10AB11
HSA approval date: 3 July 2013
Manufacturer(s):
- Fournier Laboratories Ireland Limited
- Mylan Laboratories SAS
Manufacturing country/countries: FRANCE; IRELAND
What are the HSA registration number and classification for Trilipix Modified Release Capsules 45mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14375P
Classification: Prescription Only
What active ingredients and strength are recorded for Trilipix Modified Release Capsules 45mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Choline Fenofibrate 59.6mg eqv Fenofibric Acid
Strength: 45mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Trilipix Modified Release Capsules 45mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Route: ORAL
Who is the recorded registrant for Trilipix Modified Release Capsules 45mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Which manufacturers and countries are listed for Trilipix Modified Release Capsules 45mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Fournier Laboratories Ireland Limited
- Mylan Laboratories SAS
Manufacturing country/countries: FRANCE; IRELAND
Where can I look up Trilipix Modified Release Capsules 45mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14375P or the exact product name Trilipix Modified Release Capsules 45mg. The general register link does not preselect this product.
What are the source dates for this Trilipix Modified Release Capsules 45mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Trilipix Modified Release Capsules 45mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14375P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)